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(Objectives: To analyze the characteristics of instruments designed to
assess the health-related quality of life (HRQOL) in children, developed
or adapted from 2000 to 2010 in Argentina, Chile, Mexico, Spain, and
Uruguay. Methods: The protocol-led literature review included data-
ase searching (e.g., Medline, ISI Science Citation Index) and manual
earching to retrieve studies focused on measures of HRQOL, health
tatus, or well-being addressed to children and adolescents. Country-
pecific filters were applied to identify studies carried out in the
articipating countries. The characteristics of the instruments and
ype of studies were analyzed. Descriptive characteristics and psy-
hometric properties were analyzed following the guidelines of the
cientific Advisory Committee of the Medical Outcomes Trust.
esults: Ninety-nine documents were included. Thirty-one question-
aires were identified, 24 instruments were adapted, and the psycho-
etric properties of 20 HRQOL instruments were reported in the study
eriod. There was substantial variability in the number and character-
ch Un
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doi:10.1016/j.jval.2011.11.028stics of the dimensions included. Reliability was generally acceptable,
nd the majority of instruments provided data on internal consistency
n 18) and, to a lesser extent, on test-retest reliability (n 12). Nearly
all studies reported construct validity, but only four analyzed sensitiv-
ity to change. Conclusions: There is a scarcity of instruments to mea-
sure HRQOL of children and adolescents in the countries analyzed.
Certain psychometric characteristics have been reasonablywell tested,
but others, most notably sensitivity to change, have not been tested in
most instruments. Extension of this study to other Latin American
countries would help to further identify gaps in this area and promote
the use of HRQOL measurement in children and adolescents in Span-
ish-speaking cultures.
Keywords: adolescents, children, health-related quality of life, psycho-
metric properties.
Copyright © 2012, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
There is a growing interest in assessing the health-related quality
of life (HRQOL) in children and adolescents [1]1. Currently, there is
no consensus regarding the theoretical framework and concepts
to be measured for this purpose [2], which may include children’s
health status, QOL, HRQOL, satisfaction, and well-being. Never-
theless, a recent systematic review has identified nearly 100 ge-
neric and disease-specific instruments addressed to children and
adolescents [3]. Most of these instruments have been developed in
English-speaking cultures, whereas less attention has been paid to
this area in Spanish-speaking countries and cultures. Aprevious sys-
tematic reviewofHRQOL instruments targeting children and adoles-
cents publishedup to the year 2000 in Spain identified 15 generic and
disease-specific instruments [4]. More than half the currently avail-
able instruments, however, were published after 2001 [3].
The advances in health care and health technology and rapid
developments in the field of patient-reported outcome (PRO)mea-
* Address correspondence to: Luis Rajmil, Health Services Resear
Barcelona Biomedical Research Park (Office 138.03), Doctor Aiguad
E-mail: lrajmil@imim.es; lrajmil@aatrm.catsalut.cat.
1098-3015/$36.00 – see front matter Copyright © 2012, Internation
Published by Elsevier Inc.sures imply a need to update and refine reviews of HRQOL instru-
ments and their psychometric characteristics. These reviews
would help researchers seeking to choose the best instrument for
their needs andwould serve as ameans to promote the use of PRO
instruments, especially in Spanish-speaking countries where
their use is relatively recent. Moreover, cross-cultural issues
should be taken into account when conducting multicenter and
international studies using PRO instruments. Spanish-speaking
countries include a population of approximately 450 hundredmil-
lion individuals, with a high proportion of children and adoles-
cents; hence, there is a clear need to determine the current status
of available resources enabling HRQOL measurement in children
living in these countries.
The objectives of this study were to analyze the characteristics
of instruments designed to assess HRQOL in children, developed
or adapted from 2000 to 2010 in Argentina, Chile, Mexico, Spain,
andUruguay; to describe the studies reportingHRQOLmeasures in
children in the countries analyzed; and to propose recommenda-
it, IMIM-Institut de Recerca Hospital del Mar, Parc de Salut Mar,
8, E-08003 Barcelona, Spain.
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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313V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 3 1 2 – 3 2 2tions that will help improve the use and interpretation of HRQOL
measures for children in Ibero-American countries.
Methods
The literature review included PubMed, ISI web of knowledge, spe-
cific Ibero-American databases such as Scielo or Bireme, abstracts
from local congresses in the participating countries, manual
searching of previously identified manuscripts, and previous re-
views. The literature reviewwas carried out according to a common
protocol and central coordination process in Spain (L.R.). A database
(Biblio-PRO, available at: http://bibliopro.imim.es/BiblioPRO.asp)
ontaining a virtual library of outcome measures reported by Span-
sh patients was included for Spain.
To identify HRQOL instruments developed and/or published
etween January 2000 and July 2010, an original database search
as carried out by using combinations of keywords such as “child”
MeSH] OR “adolescent” [MeSH] OR adolescent* OR child* OR teen-
ge* [ti] OR kid* [ti] OR pediatr* OR pediatr* AND “questionnaires”
mh] NOT adult [mh] OR “health surveys” OR “quality of life” [majr]
R “quality of life” [ti] OR “health status” [majr] OR “health status”
ti] OR “functional status” [ti] OR “well being” [ti] OR “perceived
ealth status.” Age limits (0–18 years), language (Spanish, French,
nglish, German), and filters for each country were also applied.
he literature review strategy is available from the authors on
equest.
Inclusion and exclusion criteria
For a specific country to be included in the study, at least one
researcher from the Ibero-American International Network on
HRQOL in Children from the country in question had to be partic-
ipating in the study. The dates to review were limited taking into
account the previous Spanish review [4].
Documents were included if they reported on subjective mea-
sures intended to collect data on QOL, health status, well-being, or
functional status in samples of children from the participating
countries. Documents reporting the use of symptom checklists
(e.g., regarding diet and nutrition, physical activity, psychiatric
symptoms), editorials, and opinion articles were excluded, as well
as those using instruments developed for the adult population,
except when it was possible to analyze the children sample sepa-
rately. Three researchers (M.R., A.U., and L.R.) conducted a pilot
test analyzing the first 70 documents fromPubMed. The number of
documents included ranged from 5 to 7; 10 to 12 documents were
classified as uncertain; and agreement (Kappa Index) was 0.45 to
0.71. A consensus process involving conference calls among the
participating researchers was carried out to decide on inclusion/
exclusion of each document.
Variables and analysis
Documents included were stratified according to the type of study
in terms of its purpose regarding HRQOLmeasurement: initial de-
velopment or adaptation of an instrument (forward and back
translation followed by qualitative techniques such as cognitive
interviews.), analysis of psychometric properties of a previously
developed or adapted instrument, observational study using a
previously validated instrument or a nonstandardized HRQOL
measure, and interventional or experimental study.
Cultural and language adaptations and translations and the
methods used to achieve conceptual equivalence were assessed.
We recorded whether at least one forward and back translation
had beenperformed andhowdifferences between the original and
translated versions were resolved. The extent of participation by
the target population (cognitive debriefings) and differences and
similarities relative to the population involved in the original de-
velopment processwere also assessed. Cross-cultural equivalencewas scored as follows: 0, nonstandardized or incomplete process;
1, at least one forward and back translation and reconciliation; 2,
previous process plus cognitive debriefing with target population;
3, full process including detailed explanations about differences
relative to the original version and solutions given; 4, original ver-
sion; and NA, not enough available information.
The following characteristics were analyzed from studies as-
sessing an instrument’s psychometric properties: country of ori-
gin, age range, type of respondent (child/adolescent self-report,
parent/proxy, both), number of dimensions and items, psycho-
metric properties (ceiling andfloor effects, reliability, validity, sen-
sitivity to change), and country in which the instrument was
adapted or validated. Generic and disease-specific instruments
are presented separately in the “Results” section. Different ver-
sions of the same instrument (e.g., versions for different age
groups, short versions) were also considered, and their psycho-
metric properties are summarized in the “Results” section. For
each instrument included in this analysis, the psychometric prop-
erties of reliability, validity, and sensitivity to change were evalu-
ated in accordance with recommendations in the scientific litera-
ture on the desirable characteristics of HRQOL instruments [5,6].
Reliability refers to the extent to which the instrument is free
from random error, and it is usually assessed by measuring the
scale’s internal consistency and test-retest reliability [7]. Internal
consistency refers to the fact thatall itemsarehomogeneousandmea-
sures specific aspects of a scale,while test-retest reliability refers to the
reproducibility or stability over time of domain and overall scores
when the conditions of measurement do not change [8,9]. Range on
the reliability coefficient was collected when it was available.
Validity is the extent to which an instrument measures what it
intends to measure [5,10]. Content validity refers to the evidence
that the content domain of an instrument is appropriate for its
intended use. In the present study, content validity was assessed
by analyzing participation of the target population (and the age
range when available) in the process of item development, and by
looking at the available information on the use of expert panel
judgment for assessing the clarity, comprehensiveness, and re-
dundancy of the instrument’s items and scales. Content validity
was classified according to whether expert opinion was the main
source of information or the target population (children or par-
ents) was themain source. Construct validitymeasures the extent
to which the questionnaire confirms a priori hypotheses, includ-
ing its capacity to detect expected differences between groups of
subjects (known groups validity) or associationswith other instru-
ments measuring constructs expected to be directly correlated
(convergent and discriminant validity). Criterion validity refers to
the degree to which scores on the instrument being validated cor-
relatewith scores on an externalmarker,which can be accepted as
the reference standard, for example, when scores on a dimension
measuring academic achievement are compared with results on
school reports. Exploratory factor analysis and confirmatory factor
analysis were also used as indicators of the structural validity of
the instruments analyzed. Exploratory factor analysis and confir-
matory factor analysis in particular reflect a priori expectations of
a theoretical-conceptual model based on clinical and biopsycho-
social models. Sensitivity to change refers to the ability of the ques-
tionnaire to detect clinically important changes in health status or
HRQOL over time [5]. This factor can bemeasured in various ways,
such as the standardized response mean andmeasurement error,
but in the great majority of cases, it was assessed by calculating
the effect size. Reporting on the type of validity assessed and sen-
sitivity to change (yes/no) was also analyzed in the present study.
A comparison on the extent to which the validated instruments
included similar domain and item content was carried out by ex-
amining the name and content of domains and items from generic
instruments.
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A total of 99 documents were ultimately included in the analysis
(Fig. 1): 59 were from Spain, 16 from Argentina, 9 from Mexico, 8
from Chile, 3 from Uruguay, and 4 studies included 2 to 4 of the
participating countries (Uruguay and Spain [11], Argentina, Mex-
ico, and Spain [12], and Argentina, Chile, Mexico, and Spain
13,14]). Sixty studies were published after 2005.
The types of studies performed and their characteristics are
shown in Table 1. Thirty-three studies analyzed the psychometric
PubMed (3694) ISI Web  (392) Manual search and other sources (59)
4145
Title and abstracts
251
Duplicates  + other  criteria
137
Full text 
99Included in the analysis =
Fig. 1 – Literature review. Search strategy.
Table 1 – Studies on health-related quality of life in childre
Type of study Number of
studies
I
Adaptation/first step including qualitative
methods [12,15-24]
11 CD-DUX, CHIP
KIDSCREEN
TAPQOL, VS
Psychometric properties of adapted/
developed instruments [25-57]
33 ACS, CDQLI, C
EBBIT, EQ-5
KIDSCREEN
PedsQL, PIQ
48, QUALIN
Observational study (descriptive or
analytic) [13,58-98]
49 BSQ, BESAA, C
KIDSCREEN
satisfaction
self-esteem
VSP-A, YQO
Experimental study [11,99,100-103] 6 CHAQ, CHIP, C
PAQLQ, Ped
AD-48
Total 99
ACS, Adolescent Coping Scale; BSQ, Body Shape Questionnaire; BESA
Life Questionnaire for Childrenwith Celiac Disease; CHAQ, Child Heal
Index; CHIP, Child Health and Illness Profile; CHIP-CE, CHIP, Child H
C-OIDP, Child-Oral Impact of Daily Performance; EBBIT, Eating Beha
Youths; Haemo-QoL, Haemophilia Quality of Life Questionnaire; HUI
naire for Children andYoung People and their Parents; KINDL, Generic
Thrombopenic purpura (Immune Thrombopenic Purpura); OSA, obs
Pediatric Asthma Quality of Life Questionnaire; PedsQL, Pediatric Qu
Dermatitis; PODCI, Pediatric Outcome Data Collection instrument; PR
Physical Self-Description Questionnaire; QUALIN, Quality of Life in
Adolescents; Self-esteem questionnaire, Coopersmith Questionnaire
sters; SPPC, Self- Perception Profile for Children; TAPQOL, Netherlan
child quality-of-life questionnaire; VSP-A, Vecu et Santé Perçué de l’Adoleproperties of adapted or developed instruments, and 11 others
were focused on either the initial development process or the first
step in adapting a questionnaire by forward and back translations
and cognitive interviews with children and parents. Six of 99 arti-
cles were experimental studies that reported the results of inter-
ventions for different clinical problems (e.g., asthma), and one
study, which assessed the impact of an intervention in asthmatic
children, included youths from Spain and Uruguay [11] among
other countries.
Information on cross-cultural adaptation of 10 generic and 14
disease-specific questionnaires is presented in Tables 2 and 3. One
instrument was administered after a simple translation [58],
whereas the majority included a forward and back translation.
Cognitive debriefing with the target population and comparisons
with the original version were carried out in most of the instru-
ments analyzed, although no information was available on the
participation of children and parents in the adaptation process in
one generic and four disease-specific instruments. In three cases,
children and adolescents from Spain had participated in the de-
velopment of the original version. The number and characteristics
of dimensions varied from a single score on HRQOL in four specific
instruments up to 15 dimensions. Overall, 15 generic and 17 dis-
ease-specific instruments were identified in the present study,
and validation studies including information on the psychometric
properties were published for 20 of these instruments during the
study period.
The psychometric properties of the generic and disease-spe-
cific instruments, respectively, are summarized in Tables 4 and 5.
Eight instruments were developed in the United States, and four
d adolescents in Ibero-American countries (2000–2010).
ment(s) Sample size
(range)
Comments
EQ-5D-Y, Haemo-QoL,
ITP, PedsQL, SMILEY,
6–44 Initial steps of forward and back
translation, and cognitive
interviews with children and
parents
P, CHAQ, CHQ, CHIP,
Haemo-QoL,
DL, PAQLQ, PACES,
, PSDQ, QOLIE-AD-
, VSP-A
64–1678 Validation as the next step or
included in the same study of
the initial development
CHQ, HUI,
DL, Overall
LQ, PODCI, QUALIN,
tionnaire, TAPQOL,
15–6639 Most of the studies were cross-
sectional and descriptive
Haemo-QoL, OSA,
PRQLQ, PSDQ, QOLIE-
27–311 Five studies based on clinical
settings. One study based on
community preventive
intervention program
6–6639
e Body Esteem Scale for Adolescents and Adults; CD-DUX, Quality of
sessment Questionnaire; CDQLI: Children’s Dermatology Quality Life
and Illness Profile-Child Edition; CHQ, Child Health Questionnaire;
and Body Image Test for Preadolescent Girls; EQ-5D-Y, Euro-Qol-5D
th utility index; KIDSCREEN, Health Related Quality of Life Question-
anQuality of Life Questionnaire for Children; KIT ITP, Kid’s Immune
ive sleep apnea; PACES, Physical Activity Enjoyment Scale; PAQLQ,
of Life Inventory; PI-QoL-AD, Parent’s Index of Quality of Life-Atopic
, Paediatric Rhinoconjunctivitis Quality of Life Questionnaire; PSDQ,
g children; QOLIE-AD-48, Quality of Life in Epilepsy Inventory for
LEY, Simple Measure of Impact of Lupus Erythematosus in Young-
ganisation for Applied Scientific Research-Academic Medical Centren an
nstru
-CE,
, KIT
P-A
-OID
D-Y,
, KIN
ol-AD
, SPPC
HIP,
, KIN
, PAQ
ques
L-R
HQ,
sQL,
A, Th
th As
ealth
viors
, heal
Germ
truct
ality
QLQ
youn
; SMI
ds Orscent; YQOL-R, Youth Quality of Life Instrument- Research version.
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315V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 3 1 2 – 3 2 2were simultaneously developed in more than one country. Most
instruments include both self- and parent-reported versions, but
questionnaires addressed to children younger than 6 to 8 years
collected information only from parents, with a few exceptions.
Content validity was explicitly assessed in almost all instruments,
and children participated through focus groups or individual in-
terviews in 11 instruments. Ceiling andfloor effects showed awide
range of scores, although this information was not available for
some disease-specific instruments. There was substantial vari-
ability in the number and characteristics of the items included
(n  5–183). Reliability was generally acceptable, and most instru-
ents provided data on internal consistency (n  18) and, to a
esser extent, on test-retest reliability (n  12). Nearly all instru-
ents reported known group validity, but only four analyzed sen-
itivity to change. Domain and item contents of generic instru-
ents included physical, psychological, and social aspects to
ome extent in all validated instruments, although the number of
imensions and items varied considerably. In general, instru-
Table 2 – Characteristics of cross-cultural adaptation, parti
generic instruments adapted in Ibero-American countries
Instrument Version-country*
(cross-cultural
adaptation†)
Population participating in
cross-cultural adaptation (n)
CHQ A (3) Pa: Cognitive testing (30)
Cl (3) Pa: Interviews (20)
Mx (3) Incomplete process of adaptation
although Pa reported feasibility
(21)
S (3) Pa: Cognitive testing (19)
CHIP S (3) Ch: Cognitive testing (44); Pa (12)
EQ-5D-Y S (4) Ch: Cognitive testing (20)
KIDSCREEN A (3) Ch: Cognitive testing (18); Pa:
Interviews (6)
S (4) Ch: Four focus groups (34); Pa:
Interviews (5)
KINDL S (2) Ch: Comments collected on a
pretest administration (445)
Cl (NA)
PedsQL A (3) Ch: (44) and Pa: (51)
Cognitive testing
S (3) Ch: Cognitive testing (10)
Uy (3) Ch: (20) and Pa: (29) Cognitive
testing
QUALIN S (2) Process carried out by experts
SPPC S (NA) NA
TAPQOL S (3) Pa: Cognitive testing (6)
VSP-A S (3) Ch: Two focus groups (8)
CHIP, ChildHealth and Illness Profile; EQ-5D-Y, CHQ, ChildHealthQue
Questionnaire for Children and Young People and their Parents; KIN
Pediatric Quality of Life Inventory; QUALIN, Quality of Life in young
Organisation for Applied Scientific Research-Academic Medical Cen
l’Adolescent.
* A, Argentina; Cl, Chile; Mx, Mexico; S, Spain; U, Uruguay; Ch, childr
† Process of cross-cultural adaptationwas computed as follows: 0, no
translation and reconciliation; 2, previous process plus cognitive d
nation of differences relative to original version and solutions giveents originally based on adult population measures (e.g., Euro-ol-5D Youths) included social constructs to a lesser extent than
id the remaining instruments (Fig. 2).
Discussion
There is a scarcity of instruments designed to measure HRQOL in
children and adolescents of the Spanish-speaking countries ana-
lyzed. The present review retrieved only one-third the number of
instruments identified in a previous review focused on other
world regions [3], and specifically, the dearth of disease-specific
instruments is notable.
The present study attempts to update the literature review in
an area of rapid development over the last years and to determine
the extent to which HRQOL instruments are used in children in
Spain and Ibero-American countries. Multinational studies are
needed to analyze the impact of specific treatments in different
contexts orwhen the prevalence of a condition under study is very
ion of target population, and dimensions included in
–2010).
Age
ge (y)
ildren)
Dimensions
5–18 Global health, physical functioning, role/social limitations,
emotional/behavioral, role/social limitations—physical,
bodily pain/discomfort, behavior, global behavior,
mental health, self-esteem, general health perceptions,
change in health, parental impact—emotional, parental
impact— time, family activities, family cohesion
6–18
2–18
5–18
6–12 Comfort, satisfaction, resilience, risk avoidance,
achievement
8–18 Mobility, usual activities, pain/discomfort,
anxiety/depression
8–18 Physical well-being, psychological well-being, moods and
emotions, self-perception, autonomy, parent relations,
social support and peers, school environment, social
acceptance, financial resources
8–18
8–16 Physical well-being, psychological well-being, self-esteem,
family, peers, school
4–16
2–18 Physical functioning, emotional functioning, social
functioning, school functioning
9–17
2–18
— Motor development, psychopathology, family context,
socialization
— Scholastic, social, athletic, physical, behavioral, global
self-worth
o to 5 y Sleeping, appetite, stomach problems, skin problems, lung
problems, motor functioning, communication, social
functioning, problem behavior, anxiety, liveliness
–17 y Vitality, physical well-being, psychological well-being,
body image, relations with friends, relations with
parents, relations with teachers, school work, leisure
naire; Euro-Qol-5DYouths; KIDSCREEN,Health RelatedQuality of Life
eneric German Quality of Life Questionnaire for Children; PedsQL,
en; SPPC, Self-Perception Profile for Children; TAPQOL, Netherlands
hild quality-of-life questionnaire; VSP-A, Vecu et Santé Perçué de
olescents; Pa, parents.
dardized or incomplete process; 1, at least one forward and one back
fing with target population; 3, full process including detailed expla-
riginal version; NA, not enough available information.cipat
(2000
ran
(ch
1
1
3 m
12
stion
DL, G
childr
tre c
en/ad
nstan
ebrielow (i.e., rare diseases) and a multicenter design is required to
n; 4, o
316 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 3 1 2 – 3 2 2increase the sample size. Thus, it would be desirable to develop
adapted versions of HRQOL instruments for children and adoles-
cents in all participating countries to facilitate these studies.
More than half the studies were from Spain, and in general, the
number of studies from Ibero-American countries has increased
over the last years, as has also occurred in other world regions [3],
a fact that reflects the increasing interest in the area of HRQOL in
children worldwide.
Adaptation of instruments in Spanish-speaking countries gen-
erally followed international guidelines [104], with the use of for-
ward and back translations. As was mentioned in the “Results”
section, only one instrument was administered after a simple
translation [58]. Nonetheless, the available information about the
Table 3 – Characteristics of cross-cultural adaptation, parti
disease-specific instruments adapted in Ibero-American co
Instrument Version-country*
(cross-cultural
adaptation†)
Population participating
in cross-cultural
adaptation (n)
ACS A (NA) NA
BESAA A (0) Translation made by experts
without participation of
the target population
CD-DUX A (3) Ch: Cognitive testing (20); Pa
(20)
CDQLI Mx (3) Ch: Cognitive testing (60)
C-OIDP S (3) Pilot test administration
testing feasibility and %
missing (30)
EBBIT S (2) NA
Haemo-QoL S (4) Ch and Pa: Cognitive testing;
total of 57 Ch and 58 Pa
from six European
countries (n from Spain
NA)
KIT ITP Uy (3) Ch: (12) and Pa: (20)
Cognitive testing
PAQLQ S (3) Ch and Pa: (11) Cognitive
testing
Uy (3) Ch and Pa: Pilot test (10)
PACES S (3) NA
PIQoL-AD S (3) Pa: Cognitive testing (20)
PSDQ S (3) Ch: Pilot test (27)
QOLIE-AD-48 S (3) Ch: Pretest administration
testing feasibility and %
missing (10)
SMILEY A (2) NA
Mx (2) NA
S (2) NA
ACS, Adolescent Coping Scale (coping); BESAA, The Body Esteem S
Questionnaire for Children with Celiac Disease (celiac disease); CDQL
Oral Impact of Daily Performance (oral-related conditions); EBBIT, Ea
iors in girls); Haemo-QoL, Haemophilia Quality of Life Questionnaire
Thrombopenic purpura (Immune Thrombopenic Purpura); PACES, Ph
Quality of Life Questionnaire (asthma); PI-QoL-AD, Parent’s Index
Self-Description Questionnaire (physical area); QOLIE-AD-48, Quality
Measure of Impact of Lupus Erythematosus in Youngsters (systemic
* A, Argentina; Cl, Chile; Mx, Mexico; S, Spain; U, Uruguay; Ch, childr
† Process of cross-cultural adaptationwas computed as follows: 0, no
translation and reconciliation; 2, previous process plus cognitive d
nation of differences relative to original version and solutions givetranslation and adaptation process was insufficient in some cases[59,105], some instruments were adapted before the study period
[60,99,106], and in other cases, no attempt was made to develop a
specific standardized instrument, but instead, exploratory factor
analysis was used to analyze the relationship between specific
concepts or constructs and overall life satisfaction [61,107,108].
Therewas sufficient information to acceptably review the psycho-
metric properties of the remaining instruments identified, except
for the ceiling and floor effects in certain disease-specific instru-
ments. Development of new or adapted instruments to a target
language should include information on its appropriateness for
thepopulationwhere itwill beused, or at least expert judgmentof its
content validity. Some psychometric characteristics have been rea-
sonably well tested in the instruments analyzed, but others, notably
ion of target population, and dimensions included in
ies (2000–2010).
e range (y)
children)
Dimensions
— Peer rejection, family deficits and parent rejection,
personal inadequacy, significant separation
— General feeling about appearance, body esteem-
weight satisfaction, body esteem-attribution
8–18 Communication, diet, having celiac disease
6–16 Single index of HRQOL
11–12 Eating, speaking, cleaning teeth, relaxing, emotion,
smiling, studying, social contact.
— Body image dissatisfaction and food restriction,
binge eating behavior, compensatory behavior
associated with eating disorders
4–16 Physical health, feeling, view, family, friends,
perceived support, others, sports, dealing,
treatment, future, relationship
(Ch)/7–17 (Pa) Single index of HRQOL
11–17 Symptoms, activity limitations, emotional function
NA
— Single score of HRQOL
8 Single score of HRQOL
12–13 Health, coordination, activity, body fat, sport
competence, physical appearance, strength,
flexibility, physical fitness
10–19 Epilepsy impact, memory-concentration, attitudes,
physical function, stigma, social support, school
behavior, health perceptions
— Effect on self, limitations, social, and burden of
systemic lupus erythematosus (SLE)—
—
for Adolescents and Adults (self-esteem); CD-DUX, Quality of Life
ldren’s Dermatology Quality Life Index (skin diseases); C-OIDP, Child
ehaviors and Body Image Test for Preadolescent Girls (eating behav-
philia); HRQOL, health-related quality of life; KIT ITP, Kid’s Immune
l Activity Enjoyment Scale (physical area); PAQLQ, Pediatric Asthma
ality of Life-Atopic Dermatitis (atopic dermatitis); PSDQ, Physical
ife in Epilepsy Inventory for Adolescents (epilepsy); SMILEY, Simple
erythematosus).
olescents; Pa, parents.
dardized or incomplete process; 1, at least one forward and one back
fing with target population; 3, full process including detailed expla-
riginal version; NA, not enough available information.cipat
untr
Ag
(
5–15
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I, Chi
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ebriethe sensitivity to change, have not been tested in most of them. Es-
Table 4 – Description of psychometric properties of the generic health-related quality of life instruments for children and adolescents developed or adapted in
Ibero-American countries (2000–2010)*.
Instrument Country of
origin
Age
range
(y)
N (range) Respondent Number
of items
Answer
categories
Ceiling/floor effect
(range of %)
Internal
consistency
Test-retest
reliability
Validity Sensitivity to
change
Countries
CHQ United States 6–18 124–182 Parent 50 Variable 0.8–75.0/0.0–4.2 0.50–0.97 0.40–1.00 Known groups convergent,
discriminant, criterion,
CV (2)
 A, Cl, Mx, S
CHIP (CHIP-AE) United States 12–19 487–902 Self-report 183 Variable 0.0–4.5/0.0–0.8 0.65–0.94 0.57–0.93 Known groups, convergent,
discriminant, EFA,
criterion, CV (1)
NA S
(CHIP-CE/CRF)
and (CHIP-
CE/PRF)
5–12 836–979 Self- and parent-
report
44–75 Likert-5 0.0–2.8/0.0–0.3 0.60–0.79 0.69–0.80 Known groups, convergent,
discriminant, CFA, CV (2)
NA S
EQ-5D Y International 8–18 973 Self-report 5 Likert-3 77.8–98.6/0.0–2.6 NA 0.86–0.99 Known groups, convergent,
discriminant, CV (1)
NA S
KINDL Germany 8–16 243–447 Self-report 24 Likert-5 4.2–19.4/0.0–0.5 0.10–0.87 0.52–0.80 Known groups, convergent,
EFA, CV (1)
NA Cl, S
KIDSCREEN-52
and 27-item
version
International 8–18 358–1678 Self- and parent-
report
27–52 Likert-5 8.7–44.8/0–1.7/ 0.70–0.90 0.55–0.79 Known groups, convergent,
discriminant, EFA, CFA,
CV (2)
 A, Cl, S
PedsQL United States 2–18 392–511 Self- and parent-
report
23 Likert-5 0.0–20.2/0.0–0.5 0.59–0.96 NA Known groups, convergent,
discriminant, CFA, CV (2)
NA A, S
PSDQ Australia 12–16 976 Self-report 70 Likert-6 NA 0.79–0.93 NA CFA, CV (NA) NA S
QUALIN France 0–3 300 Parent-report 33–34 Likert-6 NA 0.75–0.86 NA Known groups, CV (1) NA S
SPPC United States 9–12 143 Self-report 36 Likert-4 NA NA NA Known groups, EFA, CV
(NA)
NA S
VSP-A France 12–18 291 Self-report 39 Likert-5 0.0–26.1/0.0–6.1 0.69–0.91 0.69–0.84 Known groups, convergent,
discriminant, CV (2)
NA S
CFA, confirmatory factor analysis; CHIP, Child Health and Illness Profile; CHIP-AE, Child Health and Illness Profile-Adolescent Edition; CHIP-CE/CRF, Child Health and Illness Profile Child-Edition,
Child Report Form; CHIP-CE/PRF, Child Health and Illness Profile Child-Edition, Parent Report Form; CHQ, Child Health Questionnaire; EFA, exploratory factor analysis; CV, content validity (1, expert
opinion was the main source of information; 2, target population was the main source for CV); EQ-5D-Y, Euro-Qol-5D Youths; KINDL, Generic German Quality of Life Questionnaire for Children;
KIDSCREEN, Health Related Quality of Life Questionnaire for Children and Young People and their Parents; NA, Not available; PedsQL, Pediatric Quality of Life Inventory; PSDQ, Physical
Self-Description Questionnaire; QUALIN, Quality of Life in young children; SPPC, Self-Perception Profile for Children; VAS, visual analogue scale; VSP-A, Vecu et Santé Perçué de l’Adolescent.
* Includes all available information from each instrument.
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Table 5 – Description of psychometric properties of the disease-specific health-related quality of life instruments for children and adolescents developed or adapted
in Ibero-American countries (2000–2010)*.
Instrument Country of
origin
Age range (y) N (range) Respondent Number
of items
Answer
categories
Ceiling/floor effect
(range of %)
Internal
consistency
Test-retest
reliability
Validity Sensitivity
to change
Countries
ACS Australia 13–15 800 Self-report 46 Likert-5 NA 0.56–0.73 NA EFA
CV (NA)
NA A
C-OIDP United States 11–14 425 Self-report 8 NA 0.68 0.98 Known groups
CV (2)
NA S
CDLQI United
Kingdom
11.8 (average) 64 Self-report 10 Likert-4 NA 0.76–0.88 0.53–0.97 CV (1) NA Mx
CHAQ United States 1–19 121–182 Self- and parent-
report
30 Likert-4  VAS 0.0–2.2/76.0–88.0 0.94 0.95 Known groups
CV (2)
 A, Cl, Mx, S
EBBIT United States 7–12 525 Self-report 42 Likert-4 NA 0.90 NA Known groups, EFA
CV (NA)
NA S
Haemo-QoL International 4–16 76 Self- and parent-
report
29–91 Likert-5 0.0–7.9/0.0–61.8 0.60–0.79 0.61–0.90 Known groups,
convergent,
discriminant
CV (2)
NA S
PAQLQ Canada 6–17 97–1012 Self-report 23 Likert-7 2.0–17.2/0.0–0.0 0.86–0.96 0.71–0.83 Known groups,
convergent,
discriminant,
CV (2)
 S, Uy
PACES United States 12–18 2777 Self-report 18 Likert-7 NA 0.71–0.81 NA Known groups EFA, CFA
CV (NA)
NA S
PIQoL-AD International 2–8 153 Parent-report 28 Dichotomous 0.0–0.7/1.0–23.3 0.83–0.92 0.88 Known groups
CV (2)
NA S
QOLIED-AD-48 United States 10–19 54 Self-report 48 Likert-5 NA 0.49–0.92 NA Known groups,
convergent, CV (2)
NA S
ACS, Adolescent Coping Scale (coping); CDQLI, Children’s Dermatology Quality Life Index (skin diseases); CFA, confirmatory factor analysis; CHAQ, Child Health Assessment Questionnaire (juvenile
idiopathic arthritis); C-OIDP, Child Oral Impact of Daily Performance (oral-related conditions); CV, content validity (1, expert opinion was the main source of information; 2, target population was
the main source for CV); EBBIT, Eating Behaviors and Body Image Test for Preadolescent Girls (eating behaviors in girls); EFA, exploratory factor analysis; Haemo-QoL, Haemophilia Quality of Life
Questionnaire (hemophilia); NA, not available; PACES, Physical Activity Enjoyment Scale (physical area); PAQLQ, Pediatric AsthmaQuality of Life Questionnaire (asthma); PI-QoL-AD, Parent’s Index
of Quality of Life-Atopic Dermatitis (atopic dermatitis); QOLIE-AD-48, Quality of Life in Epilepsy Inventory for Adolescents (epilepsy); VAS, visual analogue scale.
* Includes all available information from each instrument.
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319V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 3 1 2 – 3 2 2tablishment of the sensitivity to change is a previous condition for
any instrument to be used as an outcomemeasure to detect changes
resulting from interventions in individuals or populations.
The instruments included in the present review cover most of
the dimensions that are important for children [109]. A qualitative
content analysis through grounded theory would improve the
quality of the present review, but this is out of the scope of our
study. The Euro-Qol-5D Youths instrument was primarily de-
signed for adults and later adapted to children and adolescents.
This approach can have advantages and limitations. For example,
with the use of this promising tool, future large epidemiological
and cost-effectiveness studies could include children. On the
other hand, although adaptation to young people was carried out
following a careful process of cognitive interview testing, it has a
large ceiling effect and therefore, little ability to discriminate be-
tween the better levels of health. Future studies should check the
usefulness of Euro-Qol-5D Youths in population studies in chil-
dren. In general, however, the psychometric properties of adapted
instruments achieved the standards recommended in interna-
tional guidelines, as has been seen in instruments adapted to
other world regions [3].
The most widely used instruments in more than one country
were the Child Health Questionnaire, Child Health Assessment
Questionnaire, Pediatric Quality of Life Inventory, and the Euro-
pean instrument of Screening for and promotion of health-related
quality of life in children and adolescents (KIDSCREEN) This cir-
cumstance would be an opportunity to establish comparisons and
to promote the use of HRQOL measurement in international and
multicenter studies. The specific areas in which generic and spe-
cific instruments were used in more than one country were
asthma [11] and juvenile idiopathic arthritis [13,14]. Several in-
truments are available for English-speaking countries in other
pecific areas, such as cancer, cystic fibrosis, epilepsy, and hemo-
hilia. It would be desirable to have adaptations of these instru-
Physical constructs
Psychological constructs
Social constructs
Physical acvity (ﬁtness) and daily acvies
Restricon of act.(limitaon)
Symptoms (pain)
Beliefs and feelings (vitality)
Negave feelings and symptoms
Sleep problems
Posive emoons
Self esteem and body image
Friends (feelings about friends)
School (acad. achievement/relaons w/teachers
Family involvement (relaonships with parents)
Cognive funconing
Behaviors
Contents
Negave reacons to friends
Fig. 2 – Physical, psychological, and social contents of gener
adolescents adapted and validated in Ibero-American count
Child Health Questionnaire; EQ-5D-Y, Euro-Qol-5D Youths; K
Children and Young People and their Parents; KINDL, Gener
Pediatric Quality of Life Inventory; PSDQ, Physical Self-Desc
young children; SPPC, Self- Perception Profile for Children; Vents for Ibero-American countries, such as those included here.The results of the present review suggest that the instruments
identified generally reflect the theoretical considerations regard-
ing the HRQOL concept [110]. The wide range in content and the
differences in the number of dimensions and items likely indicate
differences in the development process, the theoretical frame-
work applied, and the target population. Researchers selecting an
HRQOL instrument should consider whether the questionnaire
suits the purpose of the investigation, the dimensions covered are
relevant to the context, and the questionnaire is available for the
age group of interest. Some instruments collect self-report infor-
mation from children as young as 5 to 6 years with the help of
illustrations and/or interview administration. In general, it would
be advisable to choose both a generic and a disease-specific instru-
ment whenever possible to cover a broad range of contents and to
compare populations with different characteristics.
Techniques such as the item response theory [111], item bank-
ing, and computer adaptive testingmight also be of use to identify
items functioning differently for respondents from different
groups (e.g., gender, age, or culture/country). In this sense, the
Ibero-American International Network on HRQOL in Children and
Adolescents could help the initiative started in the United States,
the Patient Reported OutcomesMeasurement Information System
in pediatrics [112-114], regarding the development and application
of PRO instruments in children.
The limitations of the study deserve some comments. Thiswas
an exhaustive literature review, although inclusion of other data
sources may have identified additional published and unpub-
lished studies. Nevertheless, the present review covered the main
indexed databases, and presumably included the most relevant
studies in the area. Moreover, exploratory replication of the liter-
ature search from Spain in PsycINFO did not provide information
on any additional instruments. This review might have improved
with inclusion of other countries, specifically Brazil, Colombia,
and the Hispanic population of the United States. The study de-
Instruments
Q, CHIP, EQ-5DY, KIDSCREEN, PSDQ, SPPC
Q, CHIP, EQ-5DY, KIDSCREEN, PedsQL
Q, CHIP, EQ-5DY, KINDL, PedsQL
IP, KIDSCREEN, QUALIN, VSP-A
Q, CHIP, EQ-5DY, KIDSCREEN, VSP-A
Q, CHIP, KINDL, PedsQL, QUALIN
Q, CHIP, KIDSCREEN, KINDL
Q, CHIP, KIDSCREEN, KINDL, PSDQ, SPPC, VSP-A
HQ, PedsQL, QUALIN
Q, CHIP, SPPC
HQ, CHIP, KINDL, KIDSCREEN, VSP-A
HIP, PedsQL, KIDSCREEN
HIP, KIDSCREEN, KINDL, VSP-A
HQ, CHIP, KIDSCREEN, KINDL, QUALIN, VSP-A
alth-related quality of life instruments for children and
(2000–2010). CHIP, Child Health and Illness Profile; CHQ,
CREEN, Health Related Quality of Life Questionnaire for
rman Quality of Life Questionnaire for Children; PedsQL,
n Questionnaire (physical area); QUALIN, Quality of Life in
, Vecu et Santé Perçué de l’Adolescent.)
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SP-Avelopers, however, preferred to limit the number of countries to
320 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) 3 1 2 – 3 2 2those with at least one researcher from the Ibero-American Inter-
national Network onHRQOL in Children, to take advantage of their
experience, than to be more exhaustive in terms of the number of
countries included. A deeper and more standardized assessment
of the psychometric properties of the published instruments
would also improve this review [115]. Comparison of the psycho-
metric properties in different Spanish-speaking countries using a
single instrument and pooled data analysis could be the subject of
future studies.
There is an urgent need to extend HRQOL measurement to
disease-specific settings. Although 17 instruments were identified
in the present study, this number represents less than half the
number of disease-specific instruments available in English-
speaking countries [3]. It is also necessary to assess the instru-
ments’ sensitivity to change and to promote the inclusion of
HRQOL assessment in children as an outcome measure for evalu-
ating clinical and population interventions. Further steps in the
use of HRQOL assessment in children in Ibero-American countries
should also include amore in-depth interpretation of the scores to
facilitate their application in clinical practice and in health policy
interventions.
This study attempts to help researchers, clinicians, and policy-
makers in Ibero-American countries to choose the most appropri-
ate instrument available for their needs. Extension of this study to
the other Latin American countries would facilitate the identifica-
tion of gaps in this area and promote the use of HRQOL measure-
ment in children and adolescents in Spanish-speaking cultures.
Source of financial support: The authors have no other finan-
cial relationships to disclose.
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